Surgical treatment planning in newly diagnosed breast cancer patients at high risk for BRCA-1 or BRCA-2 mutation

Breast Journal

Volumn 10, Issue 6, 2004, Pages 473-474

  Chung, Maureen A ^a,b   Cady, Blake ^a  

^a BROWN UNIVERSITY   (United States)

^b APC 435 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ALGORITHM; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; EDITORIAL; FAMILY HISTORY; GENE MUTATION; HIGH RISK PATIENT; HUMAN; MASTECTOMY; TREATMENT PLANNING;

BREAST NEOPLASMS; DECISION SUPPORT TECHNIQUES; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MASTECTOMY; MUTATION;

EID: 8744296083     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2004.21666.x     Document Type: Editorial

References (9)

1. Stolier AJ, Fuhrman GM, Mauterer L, Bolton JS, Superneau DW. Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation. Breast J 2004;10:475-80.
2. Weitzel JN, McCaffey SM, Nedelcu R, MacDonald DJ, Blazer KR, Culliname CA. Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Arch Surg 2003;138:1323-28.
3. Ganguly A, Leahy K, Marshall AM, Dhulipala R, Godmilow L, Ganguly T. Genetic testing for breast cancer susceptibility: frequency of BRCA1 and 2 mutations. Genet Test 1997;2:85-90.
4. Seynaeve C, Verhoog LC, Van de Bosch LM, et al. Ipsilateral breast tumour recurrence in hereditary breast cancer following breast conservation therapy. Eur J Cancer 2004;40:1150-58.
5. Alpert TE, Haffty BG. Conservative management of breast cancer in BRCA1/2 mutation carriers. Clin Breast Cancer 2004;5:37-42.
6. Meijers-Heijboer H, Van Geel B, Van Putten WLJ, et al. Breast cancer after prophylactic bilateral mastectomy in women with BRCA1 or BRCA2 mutation. N Engl J Med 2004;345:159-64.
7. Metcalfe K, Lynch HT, Ghadirian P, et al. Contra lateral breast cancer in BRCA1 and 2 mutation carriers. J Clin Oncol 2004;22:2328-35.
8. Komenaka IK, Ditkoff B-A, Joseph K-A, et al. The development of interval breast malignancies in patients with BRCA mutations. Cancer 2004;100:2079-83.
9. Olopade OI, Artioli G. Efficacy of risk reducing salpingooophorectomy in women with BRCA-1 and BRCA-2 mutations. Breast J 2004;10(suppl. 1):555-59.